BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 2871878)

  • 21. Microtubule-associated protein-2: a new sensitive and specific marker for pulmonary carcinoid tumor and small cell carcinoma.
    Liu Y; Sturgis CD; Grzybicki DM; Jasnosz KM; Olson PR; Tong M; Dabbs DD; Raab SS; Silverman JF
    Mod Pathol; 2001 Sep; 14(9):880-5. PubMed ID: 11557784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Biological and immunological aspects of small cell carcinoma of the lung in relation to ectopic hormone production.
    Havemann K; Gropp C
    Biomedicine; 1979 Oct; 30(4):186-94. PubMed ID: 231464
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Antidiuretic hormone in patients with bronchial carcinoma (author's transl)].
    Gropp C; Havemann K; Kalbfleisch H; Luster W; Sosstmann H
    Dtsch Med Wochenschr; 1982 Jun; 107(25):974-7. PubMed ID: 6282559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE].
    Prévost A; Passemard F; Perdu D; Vallerand H; Deschamps F; Lavaud F; Larbre H
    Rev Mal Respir; 1994; 11(4):379-84. PubMed ID: 7973038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Possible causes for an increased content of blood peptide hormones in small-cell lung cancer].
    Raĭkhlin NT; Smirnova EA; Blinova SA; Deĭneko GM; Bassalyk LS
    Vopr Onkol; 1989; 35(2):203-7. PubMed ID: 2564709
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of serum growth factors and tumor markers as prognostic factors for survival in non-small cell lung cancer.
    Nieder C; Andratschke N; Jeremic B; Molls M
    Anticancer Res; 2003; 23(6D):5117-23. PubMed ID: 14981976
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroendocrine components of the bronchopulmonary tract: hyperplasias, dysplasias, and neoplasms.
    Gould VE; Linnoila RI; Memoli VA; Warren WH
    Lab Invest; 1983 Nov; 49(5):519-37. PubMed ID: 6138458
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD34-positive stromal cells in primary lung carcinomas.
    Nakayama H; Enzan H; Yamamoto M; Miyazaki E; Hidaka C; Okumichi T; Okumichi A; Kajihara H
    Oncol Rep; 2003; 10(5):1313-6. PubMed ID: 12883699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.
    Aroney RS; Dermody WC; Aldenderfer P; Parsons P; McNitt K; Marangos PJ; Whitacre MY; Ruddon RW; Wiernik PH; Aisner J
    Cancer Treat Rep; 1984 Jun; 68(6):859-66. PubMed ID: 6329508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumour markers CEA, NSE, SCC, TPA and CYFRA 21.1 in resectable non-small cell lung cancer.
    Foa P; Fornier M; Miceli R; Seregni E; Santambrogio L; Nosotti M; Cataldo I; Sala M; Caldiera S; Bombardieri E
    Anticancer Res; 1999; 19(4C):3613-8. PubMed ID: 10629660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Tumor markers in lung cancer].
    Niho S; Shinkai T
    Gan To Kagaku Ryoho; 2001 Dec; 28(13):2089-93. PubMed ID: 11791391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Selective expression of trophoblastic hormones by lung carcinoma: neurendocrine tumors exclusively produce human chorionic gonadotropin alpha-subunit (hCGalpha).
    Dirnhofer S; Freund M; Rogatsch H; Krabichler S; Berger P
    Hum Pathol; 2000 Aug; 31(8):966-72. PubMed ID: 10987258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma.
    Kohno N; Hirasawa Y; Kondo K; Fujioka S; Fujino S; Abe M; Yokoyama A; Hiwada K; Watanabe K; Nishimura J
    Cancer Detect Prev; 1997; 21(2):124-8. PubMed ID: 9101072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fuzzy logic-based tumor marker profiles including a new marker tumor M2-PK improved sensitivity to the detection of progression in lung cancer patients.
    Schneider J; Peltri G; Bitterlich N; Neu K; Velcovsky HG; Morr H; Katz N; Eigenbrodt E
    Anticancer Res; 2003; 23(2A):899-906. PubMed ID: 12820320
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High neuron specific enolase levels in bronchoalveolar lavage fluid of patients with lung carcinoma: diagnostic value, relation to serum neuron specific enolase, and staging.
    Dowlati A; Bury T; Corhay JL; Weber T; Mendes P; Radermecker M
    Cancer; 1996 May; 77(10):2039-43. PubMed ID: 8640667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of Cyfra 21-1 as a marker for lung cancer.
    Najemnik C; Mohn-Staudner A; Vetter H; Kokron O; Baumgartner G; Scheiner W; Zwick H; Koderhold G; Alth G; Dudczak R
    Wien Klin Wochenschr; 1996; 108(15):467-72. PubMed ID: 8806188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of immunohistochemical markers in non-small cell lung cancer by unsupervised hierarchical clustering analysis: a tissue microarray study of 284 cases and 18 markers.
    Au NH; Cheang M; Huntsman DG; Yorida E; Coldman A; Elliott WM; Bebb G; Flint J; English J; Gilks CB; Grimes HL
    J Pathol; 2004 Sep; 204(1):101-9. PubMed ID: 15307143
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The "neuron-specific enolase" tumor marker as a prognostic indicator in small cell bronchial carcinoma].
    Hoster M; Kirchheiner T; Rühle KH
    Pneumologie; 1995 Aug; 49(8):470-4. PubMed ID: 7479642
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of cytoskeletal proteins in small cell lung carcinoma.
    Hlozánková M; Lukás Z; Viklický V
    Gen Physiol Biophys; 1999 Dec; 18 Suppl 1():47-9. PubMed ID: 10707834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.